Recently, we studied the activity of the TEL- and ALT-TMM pathways in pan-cancer settings, showing that TEL and ALT pathway activities vary across different cancers, with ALT showing greater variability compared to TEL [13]. This evidence concerns the gene ETV6 and cancer.